Third Amendment to Specialty Pharmacy Network Agreement between Accredo Health Group, Inc. and United Therapeutics Corporation

Contract Categories: Business Finance › Modification Agreements
Summary

Accredo Health Group, Inc. and United Therapeutics Corporation have agreed to amend their existing Specialty Pharmacy Network Agreement. This amendment replaces Attachments A and E of the original agreement with new versions. All other terms and conditions of the original agreement remain unchanged and in effect. The amendment is effective as of the date it is signed by both parties.

Read More Arrow
EX-10.2 3 uthrex10203312023.htm EX-10.2 Document
Exhibit 10.2
THIRD AMENDMENT
TO
SPECIALTY PHARMACY NETWORK AGREEMENT

This Third Amendment to Specialty Pharmacy Network Agreement (this “Amendment”) is made as of the date the last Party executes this Amendment (the “Amendment Effective Date”), by and between Accredo Health Group, Inc. (“Specialty Pharmacy”), and United Therapeutics Corporation (“UT”). Specialty Pharmacy and UT are each referred to in this Agreement as a “Party,” collectively, the “Parties.”

WHEREAS, the Parties entered into that certain Specialty Pharmacy Network Agreement dated as of January 1, 2018, as may be amended (the “Agreement”); and

WHEREAS, the Parties entered into that certain Master Services Agreement dated December 18, 2013 as amended (the “MSA”); and

WHEREAS, the Parties now wish to amend the Agreement.

NOW THEREFORE, in consideration of the mutual agreements and covenants contained herein, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties hereto, intending to be legally bound, hereby agree as follows:

1.Attachments. Attachments A & E of the Agreement are hereby deleted in their entirety and are replaced with the Attachments A & E attached to this Amendment

2.Except as amended and supplemented hereby, all of the terms and conditions of the Agreement shall remain and continue in full force and effect and apply hereto.

IN WITNESS WHEREOF, each of the undersigned, duly authorized, has executed this Amendment, effective as of the Amendment Effective Date.

Accredo Health Group, Inc.

By:     /s/ Michael Hughes    
Print Name: Michael Hughes            
Title:    Managing Director            
Date: 02/13/2023 5:29 PM EST    
United Therapeutics Corporation

By:     /s/ Kevin T. Gray        
Print Name: Kevin T. Gray            
Title: SVP, Strategic Operations            
Date: 14-Feb-2023 12:55:09 PM EST    



Page 1 of 11